MAM
SONM icon

Meeder Asset Management’s DNA X Inc SONM Stock Holding History

Meeder Asset Management’s Portfolio SONM Stock Details SONM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Hold
0
– – – 2169
2021
Q3 		– Hold
0
– – – 2625
2021
Q2 		– Hold
0
– – – 2643
2021
Q1 		– Hold
0
– – – 2447
2020
Q4 		– Hold
0
– – – 2185
2020
Q3 		– Hold
0
– – – 2360
2020
Q2 		– Sell
-1
Closed -$1.6K – 2431
2020
Q1 		$1K Sell
1
-3
-75% -$14.4K ﹤0.01% 2229
2019
Q4 		$23K Buy
4
+3
+300% +$14.8K ﹤0.01% 1306
2019
Q3 		$4K Buy
+1
New +$15.3K ﹤0.01% 1835

Other funds holding SONM

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
SFI
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Meeder Asset Management's SONM Position: Q4 2021 in Review

Meeder Asset Management held its DNA X Inc (SONM) position steady in Q4 2021 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2169.

Meeder Asset Management first reported a position in SONM in Q3 2019 and has held it in 3 quarters since. The position peaked at $23K in Q4 2019. 16 funds tracked by Wall St. Rank hold SONM as of Q4 2021.

  • Meeder Asset Management held 0 shares of DNA X Inc worth $0 as of Q4 2021.
  • Meeder Asset Management left its DNA X Inc share count unchanged in Q4 2021.
  • DNA X Inc made up ﹤0.01% of Meeder Asset Management's portfolio in Q4 2021, its #2169 holding.
  • Meeder Asset Management first reported a position in DNA X Inc in Q3 2019 and has held it in 3 quarters since.
  • Meeder Asset Management's DNA X Inc position peaked at $23K in Q4 2019.
  • 16 funds tracked by Wall St. Rank held DNA X Inc as of Q4 2021.

Based on Meeder Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.